GlassScriptPhysician profile
Gloria K Anding
NPI 1245235621
$14,911.62
in general payments reported to CMS, 2019-2025
63 companies · $2,161 in 2025
The $2,161 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,489 · 2020: $1,397 · 2021: $1,913 · 2022: $2,310 · 2023: $2,245 · 2024: $2,398 · 2025: $2,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,784 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,783.73 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,390.23 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,310.53 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $1,278.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,206.37 | 2020-2025 | Ubrelvy, Vraylar, Qulipta |
| Lilly USA, LLC | $1,049.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,026.45 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $586.52 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $551.89 | 2021-2025 | |
| Astellas Pharma US INC | $530.30 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $474.70 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $473.96 | 2019-2023 | Xarelto |
| Amgen INC. | $462.53 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $442.45 | 2019-2025 | Freestyle Libre 3, Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $395.23 | 2019-2024 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.29 | 2019-2025 | Xifaxan, Trulance |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $244.83 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $240.21 | 2019-2024 | Steglatro, Belsomra, Dificid |
| Exact Sciences Corporation | $235.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $223.23 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $151.00 | 2023-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $140.95 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $136.26 | 2019-2024 | Linzess |
| Tris Pharma INC | $135.42 | 2023-2025 | Dyanavel Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $116.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $114.44 | 2019-2023 | Seglentis, Livalo |
| Dexcom, INC. | $108.23 | 2021-2025 | Dexcom G6 Transmitter |
| Azurity Pharmaceuticals, INC. | $99.73 | 2023-2025 | Edarbi, Edarbi |
| Biogen, INC. | $99.67 | 2021-2022 | |
| Genentech USA, INC. | $92.64 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $79.98 | 2022-2023 | Oxlumo |
| Eisai INC. | $79.04 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $77.08 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $76.23 | 2024-2025 | Gemtesa |
| Orexo US, INC. | $75.73 | 2019-2023 | Zubsolv |
| Arbor Pharmaceuticals, INC. | $70.66 | 2019-2021 | |
| Ibsa Pharma INC. | $70.57 | 2019-2021 | |
| Avvisto Therapeutics, LLC | $69.34 | 2024-2025 | Cycloset |
| Otsuka America Pharmaceutical, INC. | $66.52 | 2023-2025 | Rexulti |
| Aimmune Therapeutics, INC. | $57.75 | 2024-2025 | Zenpep |
| Inspire Medical Systems, INC. | $53.74 | 2024 | Inspire |
| Antares Pharma, INC. | $46.41 | 2019-2024 | Xyosted |
| Corcept Therapeutics | $44.46 | 2023 | Korlym |
| Lundbeck LLC | $43.99 | 2024-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $38.82 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $38.80 | 2022-2023 | Quviviq |
| Seqirus USA INC | $34.90 | 2025 | Flucelvax, Fluad |
| Supernus Pharmaceuticals, INC. | $33.40 | 2020-2022 | Xyosted |
| Vertical Pharmaceuticals, LLC | $24.36 | 2020 | |
| Pharming Healthcare, INC. | $24.30 | 2023 | Ruconest |
| Sunovion Pharmaceuticals INC. | $23.29 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $20.83 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.64 | 2020 | |
| Amneal Pharmaceuticals LLC | $17.78 | 2025 | Unithroid |
| Sanofi Pasteur INC. | $17.35 | 2019 | |
| Radius Health, INC. | $17.10 | 2019 | |
| Hikma Pharmaceuticals USA | $15.17 | 2023 | Mitigare, Ryaltris |
| Halozyme INC | $15.15 | 2023 | |
| Xeris Pharmaceuticals, INC. | $14.73 | 2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $14.30 | 2020 | |
| Neuronetics, INC. | $13.97 | 2019 | |
| Tolmar, INC. | $12.73 | 2023 | |
| Jazz Pharmaceuticals INC. | $12.11 | 2021 | |
| Vistapharm, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Anding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.